EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development

Breanna Caruso iD, Benjamin R Weeder, Reid F Thompson, Amy E Moran iD

ImmunoHorizons · 01.03.2024 · 8 (3) · 281-294

DOI: 10.4049/immunohorizons.2300079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoHorizons, online erschienen am 29.03.2024. Verfasst von Breanna Caruso und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR. Hauptthemen laut MEDLINE: Interleukin-2, Programmed Cell Death 1 Receptor, T-Lymphocytes, Regulatory, Thymus Gland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, CSRD VA, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibitory proteins, such as programmed cell death protein 1 (PD-1), have been studied extensively in peripheral T cell responses to foreign Ags, self-Ags, and neoantigens. Notably, these proteins are first expressed during T cell development in the thymus. Reports suggest that PD-1 limits regulatory T cell (Treg) development, but the mechanism by which PD-1 exerts this function remains unknown. The present study expands the evaluation of murine PD-1 and its ligands in the thymus, demonstrating that some of the highest expressers of PD-1 and programmed death-ligand 1 are agonist selected cells. Surprisingly, we reveal a selective role for PD-1 in regulating the developmental niche only for Tregs because other agonist selected cell populations, such as NK T cells, remain unchanged. We also ruled out PD-1 as a regulator of proliferation or cell death of agonist selected Tregs and further demonstrated that PD-1–deficient Tregs have reduced TCR signaling. Unexpectedly, the data suggest that PD-1–deficient thymocytes produce elevated levels of IL-2, a Treg niche–limiting cytokine. Collectively, these data suggest a novel role for PD-1 in regulating IL-2 production and the concurrent agonist selection of murine thymic Tregs. This observation has implications for the use of checkpoint blockade in the context of cancer and infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-2Programmed Cell Death 1 ReceptorT-Lymphocytes, RegulatoryThymus GlandAnimalsMiceCytokines

Substanzen

CytokinesInterleukin-2Programmed Cell Death 1 ReceptorPdcd1 protein, mouse

Autor:innen und Institutionen

  • Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR.
  • Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR.
  • Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
  • Department of Radiation Medicine, Oregon Health and Science University, Portland, OR.
  • Veterans Affairs Portland Health Care System, Portland,OR.

ORCID-Profile: Breanna Caruso, Amy E Moran

Förderung

  • NCI NIH HHS
  • CSRD VA
  • National Science Foundation
  • National Cancer Institute
  • National Institutes of Health
  • OHSU Foundation

Zitieren

APA

Caruso, B., Weeder, B. R., Thompson, R. F., & Moran, A. E. (2024). PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development. ImmunoHorizons, 8(3), 281-294. https://doi.org/10.4049/immunohorizons.2300079

Vancouver

Caruso B, Weeder BR, Thompson RF, Moran AE. PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development. ImmunoHorizons. 2024;8(3):281-294. doi:10.4049/immunohorizons.2300079

BibTeX
@article{Caruso2024,
  author = {Caruso, Breanna and Weeder, Benjamin R and Thompson, Reid F and Moran, Amy E},
  title = {PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development},
  journal = {ImmunoHorizons},
  year = {2024},
  volume = {8},
  number = {3},
  pages = {281--294},
  doi = {10.4049/immunohorizons.2300079}
}
Kostenlos starten →